Drug Type Bispecific antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism APRIL inhibitors(Tumor necrosis factor ligand superfamily member 13 inhibitors), BAFF inhibitors(B-cell-activating factor/B lymphocyte stimulator inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glomerulonephritis, IGA | Phase 1 | China | 02 Jun 2026 | |
| Idiopathic Membranous Glomerulonephritis | Phase 1 | China | 02 Jun 2026 | |
| Lupus Nephritis | Phase 1 | China | 02 Jun 2026 |






